 |
 |
[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Cost effectiveness in Drug Registration (cont'd)
- Subject: [e-drug] Cost effectiveness in Drug Registration (cont'd)
- From: Joel Lexchin <joel.lexchin@utoronto.ca>
- Date: Thu, 28 Jun 2001 01:39:23 -0400 (EDT)
E-drug: Cost effectiveness in Drug Registration (cont'd)
-------------------------------------------------------------------------
Cost effectiveness is a criteria for getting listed on the public
formularies in some Canadian provinces but it is not a criteria for
getting marketing approval in Canada. In the provinces that require
pharmacoeconomic studies this is not a part of the legislation but a
decision by the committee doing the evaluations.
Joel Lexchin MD
121 Walmer Rd.
Toronto, Ontario
Canada M5R 2X8
Tel: +416-964-7186
Fax: +416-923-9515
e mail: joel.lexchin@utoronto.ca
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://www.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
|